ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 77 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $5,084,000 | -34.8% | 75,000 | -32.3% | 0.74% | -29.7% |
| Q4 2016 | $7,793,000 | -0.9% | 110,842 | 0.0% | 1.05% | +21.1% |
| Q3 2016 | $7,863,000 | +45.0% | 110,842 | 0.0% | 0.87% | +12.7% |
| Q2 2016 | $5,421,000 | -21.8% | 110,842 | +1.2% | 0.77% | -26.3% |
| Q1 2016 | $6,932,000 | -43.6% | 109,500 | 0.0% | 1.04% | -29.0% |
| Q4 2015 | $12,284,000 | +16.5% | 109,500 | 0.0% | 1.47% | -12.7% |
| Q3 2015 | $10,546,000 | +1.0% | 109,500 | +7.4% | 1.68% | +21.2% |
| Q2 2015 | $10,444,000 | +64.9% | 102,000 | 0.0% | 1.39% | +41.9% |
| Q1 2015 | $6,333,000 | +20.3% | 102,000 | -15.0% | 0.98% | +20.6% |
| Q4 2014 | $5,266,000 | -22.5% | 120,000 | 0.0% | 0.81% | -41.9% |
| Q3 2014 | $6,792,000 | +26.1% | 120,000 | 0.0% | 1.40% | -2.1% |
| Q2 2014 | $5,387,000 | +83.7% | 120,000 | +100.0% | 1.43% | +111.7% |
| Q1 2014 | $2,933,000 | – | 60,000 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iguana Healthcare Management, LLC | 75,000 | $5,084,000 | 2.52% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 1,237,825 | $83,900,000 | 1.18% |
| CAPITAL INTERNATIONAL LTD /CA/ | 206,718 | $14,011,000 | 0.91% |
| Cormorant Asset Management, LP | 75,000 | $5,084,000 | 0.74% |
| Capital International Sarl | 107,450 | $7,283,000 | 0.63% |
| Rock Springs Capital Management LP | 159,750 | $10,828,000 | 0.62% |
| Opus Point Partners Management, LLC | 12,201 | $827,000 | 0.61% |
| Hood River Capital Management LLC | 109,629 | $7,431,000 | 0.56% |
| Aureus Asset Management, LLC | 50,740 | $2,927,000 | 0.51% |
| ROCKEFELLER FINANCIAL SERVICES INC | 374,663 | $25,395,000 | 0.51% |